CN113117017A - A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method - Google Patents
A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method Download PDFInfo
- Publication number
- CN113117017A CN113117017A CN201911397275.2A CN201911397275A CN113117017A CN 113117017 A CN113117017 A CN 113117017A CN 201911397275 A CN201911397275 A CN 201911397275A CN 113117017 A CN113117017 A CN 113117017A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw materials
- cerebrovascular diseases
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 36
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 35
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 55
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 15
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 15
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 15
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 14
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 14
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 13
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 13
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 13
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 13
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 12
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 12
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000006533 astragalus Nutrition 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 238000004806 packaging method and process Methods 0.000 claims abstract description 8
- 238000007873 sieving Methods 0.000 claims abstract description 8
- 238000005303 weighing Methods 0.000 claims abstract description 8
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 6
- 244000061520 Angelica archangelica Species 0.000 claims abstract 4
- 239000011812 mixed powder Substances 0.000 claims description 18
- 239000011265 semifinished product Substances 0.000 claims description 14
- 241001061264 Astragalus Species 0.000 claims description 6
- 210000004233 talus Anatomy 0.000 claims description 6
- 241001106477 Paeoniaceae Species 0.000 claims 3
- 239000008280 blood Substances 0.000 abstract description 30
- 210000004369 blood Anatomy 0.000 abstract description 29
- 210000002216 heart Anatomy 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 230000017531 blood circulation Effects 0.000 abstract description 14
- 210000004204 blood vessel Anatomy 0.000 abstract description 13
- 244000170916 Paeonia officinalis Species 0.000 abstract description 10
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 238000009499 grossing Methods 0.000 abstract description 3
- 238000004090 dissolution Methods 0.000 abstract description 2
- 210000004877 mucosa Anatomy 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 32
- 208000024891 symptom Diseases 0.000 description 17
- 208000007536 Thrombosis Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 208000002173 dizziness Diseases 0.000 description 10
- 241000125175 Angelica Species 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 8
- 208000014674 injury Diseases 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 208000010125 myocardial infarction Diseases 0.000 description 7
- 230000003860 sleep quality Effects 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000006996 mental state Effects 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010008479 Chest Pain Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 241000180649 Panax notoginseng Species 0.000 description 3
- 235000003143 Panax notoginseng Nutrition 0.000 description 3
- 206010062519 Poor quality sleep Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010047249 Venous thrombosis Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 241000185686 Apocynum venetum Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 208000033386 Buerger disease Diseases 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010063547 Diabetic macroangiopathy Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001416180 Moschidae Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 206010061876 Obstruction Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 208000001106 Takayasu Arteritis Diseases 0.000 description 2
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000010515 dystocia Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 235000007183 paleface Nutrition 0.000 description 2
- 208000001297 phlebitis Diseases 0.000 description 2
- 238000002601 radiography Methods 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 206010008088 Cerebral artery embolism Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 206010061599 Lower limb fracture Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 241000699700 Ondatra zibethicus Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 241000037826 Polygonatum kingianum Species 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000007814 Unstable Angina Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000010849 intracranial embolism Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004092 self-diagnosis Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases, which is prepared from the following raw materials in parts by weight: 20-30 parts of salvia miltiorrhiza, 15-25 parts of pseudo-ginseng, 15-25 parts of peach kernel, 10-20 parts of angelica, 10-20 parts of safflower, 10-20 parts of astragalus membranaceus, 10-20 parts of red paeony root, 5-15 parts of ligusticum wallichii, 5-15 parts of codonopsis pilosula, 5-15 parts of rhizoma polygonati and 1-10 parts of musk; the preparation method comprises the following steps: (1) weighing the raw materials; (2) pulverizing all the raw materials respectively, sieving, and mixing; (3) drying; (4) and (6) automatically and quantitatively packaging and warehousing. The product of the invention has the advantages of small dosage, simple and convenient taking, high dissolution speed, good effect, direct absorption of blood through mucosa, purification and removal of blood vessel garbage, high utilization degree, curative effect, no gastrointestinal stimulation, no obvious toxic or side effect and the like, and has good effects of promoting blood circulation, removing blood stasis, removing blood garbage, smoothing heart parts and blood vessels of the whole body.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and a preparation method thereof.
Background
Cardiovascular and cerebrovascular diseases are common diseases seriously threatening the health of human beings (particularly middle-aged and elderly people), and even if the most advanced and perfect treatment means are applied at present, more than 50 percent of the life of the accident survivors of the cardiovascular and cerebrovascular diseases cannot be managed completely. The cardiovascular and cerebrovascular diseases have the characteristics of more than four high blood vessels: high morbidity, high mortality, high disability rate, high recurrence rate and many complications.
According to statistics, the number of patients with cardiovascular and cerebrovascular diseases in China exceeds 6.7 hundred million, and the basic types are thrombus and myocardial infarction. Among them, thrombus is feared to cause local occlusion, thereby causing organ ischemia, and hypoxia and failure. Thrombus can appear in arteries of any part of a human body, coronary heart disease can be caused if the thrombus appears in the arteries of any part of the human body, cerebral infarction or cerebral embolism can be caused if the thrombus appears in the bifurcation of cerebral vessels, and sudden death can be caused if the thrombus appears in the arteries of any part of the human body.
When the coronary artery of the heart is subjected to embolism and blood flow interruption due to the aggravation of arteriosclerosis or thrombosis, so that ischemic necrosis of the myocardium is caused, the acute myocardial infarction (myocardial infarction for short) is meant in a human body. Myocardial infarction is a common disease, in China, the probability of suffering from the disease is as high as 16.2% when men are more than 60 years old, and the most direct cause of myocardial infarction is that thrombus blocks heart coronary arteries.
At present, in the aspect of treatment of cardiovascular and cerebrovascular diseases, western medical treatment is conservative, no new breakthrough is available, and the treatment effect is poor; the western surgery is limited by the surgical indications, conditions, etc. In the treatment medicines for cardiovascular and cerebrovascular diseases, the traditional Chinese medicine formula born by China for thousands of years has small side effect, the cost is lower than that of western medicines by several times, and if the traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases is popularized, tens of millions of medical expenses can be saved each year.
Therefore, how to develop a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is a problem to be solved urgently by the technical personnel in the field.
Disclosure of Invention
In view of the above, the present invention aims to provide a Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and a preparation method thereof, so as to solve the defects in the prior art. The invention is a particle product prepared by taking Chinese herbal medicines as main raw materials, has no toxicity, no harm and no hormone, can expel toxin, dissolve tumor, supplement heart qi, fill heart blood and promote blood circulation to remove blood stasis, and is an optimal product for removing blood rubbish, smoothing heart parts and blood vessels of the whole body.
In order to achieve the purpose, the invention adopts the following technical scheme:
a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is prepared from the following raw materials in parts by weight: 20-30 parts of salvia miltiorrhiza, 15-25 parts of pseudo-ginseng, 15-25 parts of peach kernel, 10-20 parts of angelica, 10-20 parts of safflower, 10-20 parts of astragalus membranaceus, 10-20 parts of red paeony root, 5-15 parts of ligusticum wallichii, 5-15 parts of codonopsis pilosula, 5-15 parts of rhizoma polygonati and 1-10 parts of musk;
preferably: 22-28 parts of salvia miltiorrhiza, 18-22 parts of pseudo-ginseng, 18-22 parts of peach kernel, 15-20 parts of angelica, 12-18 parts of safflower, 12-18 parts of astragalus membranaceus, 10-15 parts of red paeony root, 8-12 parts of ligusticum wallichii, 8-12 parts of codonopsis pilosula, 6-10 parts of rhizoma polygonati and 2-5 parts of musk.
More preferably: 25 parts of salvia miltiorrhiza, 20 parts of pseudo-ginseng, 20 parts of peach kernel, 18 parts of angelica, 15 parts of safflower, 15 parts of astragalus, 12 parts of red paeony root, 10 parts of ligusticum wallichii, 10 parts of codonopsis pilosula, 8 parts of rhizoma polygonati and 3 parts of musk.
The medicinal mechanism of the invention is as follows:
the theory of traditional Chinese medicine considers that ' no pain is caused by passing through the channels and no pain is caused by the channels, but all the diseases are caused by ' no pass '. From the perspective of traditional Chinese medicines, the salvia miltiorrhiza clears and tonifies, activates blood circulation, removes stasis and promotes qi; moschus and Notoginseng radix have effects of inducing resuscitation, refreshing mind, clearing heat and relieving pain. Therefore, the blood circulation promoting and blood stasis removing medicine is selected from peach kernel, safflower, red peony root, Szechuan lovage rhizome, salvia miltiorrhiza and angelica; the qi-tonifying herbs are selected from radix Codonopsis, radix astragali, and rhizoma Polygonati.
Wherein the Saviae Miltiorrhizae radix is dried root and rhizome of Salvia militari B.g. of Labiatae, and has bitter taste and slightly cold nature; heart and liver meridian entered; the efficacy is as follows: promoting blood circulation, removing blood stasis, dredging channels, relieving pain, clearing heart fire, relieving restlessness, cooling blood, and eliminating carbuncle; the main treatment is as follows: can be used for treating thoracic obstruction, heart pain, abdominal pain, hypochondriac pain, abdominal mass, pain due to pyretic arthralgia, vexation, insomnia, menoxenia, dysmenorrhea, amenorrhea, and pyocutaneous disease with swelling and pain.
Notoginseng, a dry root of panax notoginseng Panaxnoto g insen g (Burk.) f.h.chen of the family araliaceae, is sweet in taste, slightly bitter in taste and warm in nature; entering liver and stomach meridians; the efficacy is as follows: stasis dissipating, bleeding stopping, swelling subsiding and pain relieving; the main treatment is as follows: can be used for treating hemoptysis, hematemesis, epistaxis, hematochezia, metrorrhagia, traumatic hemorrhage, thoracico-abdominal pain, and traumatic injury with swelling and pain.
Peach kernel, which is a dry mature seed of Prunus persica (L.) Batsch or Prunus davidiana (Carr.) Franch, belonging to Rosaceae, and has bitter and sweet taste and mild nature; the heart, liver and large intestine meridians entered; the efficacy is as follows: promoting blood circulation, removing blood stasis, loosening bowel to relieve constipation, relieving cough and asthma; the main treatment is as follows: can be used for treating amenorrhea, dysmenorrhea, abdominal mass, pulmonary abscess, intestinal carbuncle, traumatic injury, intestinal dryness, constipation, cough, and asthma.
Angelica sinensis, a dried root of Ankeelia sinensis (Oliv.) Sierns (Oliv.) Diels, a plant of Umbelliferae, is sweet, pungent and warm in nature; it enters liver, heart and spleen meridians; the efficacy is as follows: enriching blood, promoting blood circulation, regulating menstruation, relieving pain, loosening bowel to relieve constipation; the main treatment is as follows: can be used for treating blood deficiency, sallow complexion, giddiness, palpitation, menoxenia, amenorrhea, dysmenorrhea, asthenia cold, abdominal pain, rheumatalgia, traumatic injury, superficial infection, pyocutaneous disease, intestinal dryness, and constipation.
Carthami flos, which is dried flower of Carthamus tinctorius L. of Compositae, and is pungent in taste and warm in nature; heart and liver meridian entered; the efficacy is as follows: promoting blood circulation, dredging channels, removing blood stasis and relieving pain; the main treatment is as follows: can be used for treating amenorrhea, dysmenorrhea, lochiorrhea, abdominal mass, thoracic obstruction, cardialgia, abdominal pain due to blood stasis, pricking pain in chest and hypochondrium, traumatic injury, and pyocutaneous disease with swelling and pain.
Radix astragali, the root of Astragalus mongholicus (Fisch.) bge of Leguminosae, is sweet in taste and slightly warm in nature; spleen and lung meridian entered; the efficacy is as follows: invigorating qi, consolidating superficial resistance, expelling toxic materials, expelling pus, promoting urination, and promoting granulation; the main treatment is as follows: can be used for treating deficiency of vital energy, asthenia, chronic diarrhea, proctoptosis, spontaneous perspiration, edema, uterine prolapse, albuminuria due to chronic nephritis, diabetes, and unhealed wound.
Radix Paeoniae Rubra is dry root of Ranunculaceae plant radix Paeoniae Rubra or radix Paeoniae Rubra, and is bitter in taste and slightly cold in nature; entering liver meridian; the efficacy is as follows: clearing heat and cooling blood, and removing blood stasis and relieving pain; the main treatment is as follows: can be used for treating heat syndrome of nutrient-blood, macula due to toxic heat, hematemesis and epistaxis, conjunctival congestion, swelling and pain, liver depression, hypochondriac pain, amenorrhea, dysmenorrhea, abdominal pain, traumatic injury, carbuncle, swelling, and sore.
Chuan Xiong is pungent in flavor and warm in nature; entering liver and gallbladder meridians; the efficacy is as follows: promoting qi circulation, relieving depression, dispelling wind-dryness and dampness, promoting blood circulation, and relieving pain; the main treatment is as follows: wind-cold headache, dizziness, hypochondriac pain, abdominal pain, cold arthralgia, spasm of tendons, amenorrhea, dystocia, postpartum stasis, pain, carbuncle, ulcer and sore.
Codonopsis pilosula, sweet in flavor and mild in nature; spleen and lung meridian entered; the efficacy is as follows: invigorating spleen, replenishing qi, and promoting fluid production; the main treatment is as follows: weakness of the spleen and stomach, deficiency of both qi and blood, lassitude, weakness, poor appetite, thirst, chronic diarrhea, and rectocele.
Rhizoma Polygonati is dried rhizome of Polygonatum kingianum Kitag annual Coll et Hemsl, Polygonatum Sibiricum Red or Polygonatum Polygram Potassium Hua, and has sweet taste and neutral nature; spleen, lung and kidney meridians entered; the efficacy is as follows: invigorating qi, nourishing yin, invigorating spleen, moistening lung, and invigorating kidney; the main treatment is as follows: can be used for treating deficiency of spleen-stomach qi, asthenia, stomach yin deficiency, xerostomia, cough with little appetite, lung deficiency, cough with excessive consumption, hemoptysis, essence and blood deficiency, soreness of waist and knees, premature gray hair, and internal heat with thirst quenching effect.
The musk is dry secretion in mature male sachet of forest musk deer moschiberezovski, muskrat M.sifanic Przewalski or original musk deer M.moschiberus Linnaeus, is pungent in taste and warm in nature; heart and spleen meridians entered; the efficacy is as follows: inducing resuscitation and refreshing mind, promoting blood circulation and dredging channels, and relieving swelling and pain; the main treatment is as follows: coma due to block syndrome, sore and ulcer, toxic swelling, scrofula, subcutaneous nodule, sore throat, amenorrhea due to blood stasis, abdominal mass, heart and abdomen pain, headache, traumatic injury, arthralgia due to wind-cold-dampness, dystocia, stillbirth and retained afterbirth.
The product of the invention has the following effects:
1. reducing blood fat, changing blood viscosity, softening blood vessel, dissolving thrombus and dredging collaterals;
2. reducing cholesterol and triglyceride, resisting thrombosis, and reducing apoplexy and myocardial infarction;
3. it has effects in promoting blood circulation, relieving hyperlipidemia, reducing cholesterol and neutral fat in blood, reducing fat retention time on blood vessel wall, promoting dissipation of atherosclerotic plaque, and preventing vascular intimal injury caused by cholesterol.
The diseases applicable to the invention are as follows:
has unique curative effect on hyperlipidemia, atherosclerosis, cerebral arteriosclerosis, coronary heart disease, thromboangiitis obliterans, diabetic arteriosclerosis, multiple Takayasu arteritis, deep and superficial venous thrombosis, varicosis, nodular phlebitis, etc.
The invention also provides a preparation method of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases, which comprises the following steps:
(1) weighing the raw materials according to the weight parts of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases;
(2) respectively crushing all the raw materials, sieving the crushed raw materials with a 180-200-mesh sieve (preferably 200 meshes), and uniformly mixing the crushed raw materials to obtain mixed powder;
(3) heating the mixed powder obtained in the step (2) to 94-98 ℃, and drying until the humidity is 0 to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
The Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases comprises the following components in parts by weight: the medicine is taken once a day, 10 g is taken orally each time.
According to the technical scheme, compared with the prior art, the invention has the following beneficial effects:
the invention extracts the active ingredients of traditional Chinese medicine worm medicine, salvia miltiorrhiza and the like by modern high technology, and adds a proper amount of musk to prepare a novel pure traditional Chinese medicine functional new material, is the crystal of the traditional Chinese medicine and modern pharmaceutical preparation technology, has the advantages of small dosage, simple and convenient taking, high dissolution speed, good effect, capability of directly absorbing blood through mucosa, purifying and removing blood vessel waste, high utilization degree, curative effect, no stimulation to stomach and intestine, no obvious toxic or side effect and the like, and has good effects on promoting blood circulation, removing blood stasis, removing blood waste, smoothing heart parts and blood vessels of the whole body.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The applicant aims at the severe health condition that modern people suffer from cardiovascular and cerebrovascular diseases due to serious pollution of food sources by pesticide residues, and the following traditional Chinese medicine formula is prepared by combining with own modern scientific knowledge and intensively researching on the basis of a secret recipe handed down from ancestors of traditional Chinese medicine. The health-care tea has the main functions of clearing blood fat and toxin accumulated in blood vessels of the whole body and even cells and achieving the purposes of disease removal and body building.
Example 1
The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is prepared from the following raw materials in parts by weight: 20 g of salvia miltiorrhiza, 15 g of pseudo-ginseng, 15 g of peach kernel, 10 g of angelica, 10 g of safflower, 10 g of astragalus, 10 g of red peony root, 5 g of ligusticum wallichii, 5 g of codonopsis pilosula, 5 g of rhizoma polygonati and 1 g of musk.
The preparation method comprises the following steps:
(1) weighing the raw materials according to the weight of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases;
(2) respectively crushing all the raw materials, sieving the crushed raw materials with a 180-mesh sieve, and then uniformly mixing the crushed raw materials to obtain mixed powder;
(3) heating the mixed powder obtained in the step (2) to 94 ℃ and drying until the humidity is 0 to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
Example 2
The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is prepared from the following raw materials in parts by weight: 22 g of salvia miltiorrhiza, 18 g of pseudo-ginseng, 18 g of peach kernel, 15 g of angelica, 12 g of safflower, 12 g of astragalus, 10 g of red paeony root, 8 g of ligusticum wallichii, 8 g of codonopsis pilosula, 6 g of rhizoma polygonati and 2 g of musk.
The preparation method comprises the following steps:
(1) weighing the raw materials according to the weight of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases;
(2) respectively crushing all the raw materials, sieving the crushed raw materials with a 180-mesh sieve, and then uniformly mixing the crushed raw materials to obtain mixed powder;
(3) heating the mixed powder obtained in the step (2) to 94 ℃ and drying the mixed powder to the humidity of 0 to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
Example 3
The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is prepared from the following raw materials in parts by weight: 25 g of salvia miltiorrhiza, 20 g of pseudo-ginseng, 20 g of peach kernel, 18 g of angelica, 15 g of safflower, 15 g of astragalus root, 12 g of red peony root, 10 g of ligusticum wallichii, 10 g of codonopsis pilosula, 8 g of rhizoma polygonati and 3 g of musk.
The preparation method comprises the following steps:
(1) weighing the raw materials according to the weight of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases;
(2) respectively crushing all the raw materials, sieving the crushed raw materials with a 200-mesh sieve, and then uniformly mixing the crushed raw materials to obtain mixed powder;
(3) heating the mixed powder obtained in the step (2) to 96 ℃, and drying until the humidity is 0 to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
Example 4
The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is prepared from the following raw materials in parts by weight: 28 g of salvia miltiorrhiza, 22 g of pseudo-ginseng, 22 g of peach kernel, 20 g of angelica, 18 g of red, 18 g of astragalus, 15 g of red peony root, 12 g of ligusticum wallichii, 12 g of codonopsis pilosula, 10 g of rhizoma polygonati and 5 g of musk.
The preparation method comprises the following steps:
(1) weighing the raw materials according to the weight of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases;
(2) respectively crushing all the raw materials, sieving the crushed raw materials with a 200-mesh sieve, and then uniformly mixing the crushed raw materials to obtain mixed powder;
(3) heating the mixed powder obtained in the step (2) to 98 ℃ and drying the mixed powder to the humidity of 0 to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
Example 5
The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is prepared from the following raw materials in parts by weight: 30 g of salvia miltiorrhiza, 25 g of pseudo-ginseng, 25 g of peach kernel, 20 g of angelica, 20 g of safflower, 20 g of astragalus, 20 g of red peony root, 15 g of ligusticum wallichii, 15 g of codonopsis pilosula, 15 g of rhizoma polygonati and 10 g of musk.
The preparation method comprises the following steps:
(1) weighing the raw materials according to the weight of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases;
(2) respectively crushing all the raw materials, sieving the crushed raw materials with a 200-mesh sieve, and then uniformly mixing the crushed raw materials to obtain mixed powder;
(3) heating the mixed powder obtained in the step (2) to 98 ℃ and drying the mixed powder to the humidity of 0 to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
Typical cases
Case 1
The patient is Luzhong, male sex, and 47 years old. Time of first visit: 10 and 3 days 2014.
Before treatment, symptoms such as headache, dizziness, tinnitus and the like often appear, hypertension exists, sometimes the patient feels faint after drinking a small amount of wine, the result shows that brain blood vessels are seriously blocked after brain nuclear magnetic resonance in hospitals, and doctors recommend that the patient can not be cured by means of medicine conditioning.
After receiving treatment, von physician advises patients to adjust diet, without drinking, smoking less, and eating greasy food. After the traditional Chinese medicine composition is taken twice a day with dosage of 150mL each time and continuously insisting for 2 weeks, the phenomenon of headache, dizziness, tinnitus and the like fed back by a patient disappears, and the patient is subjected to brain nuclear magnetic resonance in a hospital to diagnose the slight cerebrovascular blockage. After the medicine is continuously taken for about 40 days, the former symptoms disappear, the blood pressure is stable, the sleep quality is improved, and the face becomes ruddy.
Case 2
Patient Yan A, sex women, age 64. Time of first visit: 10 and 15 days 2014.
The patients often have symptoms of dizziness, distending pain of the head, severe temporocephaly, hypomnesis, inattention, poor sleep and the like in the morning, and the dizziness and the distending pain of the head are obviously aggravated after excitement or fatigue. The disease condition is obviously improved when the local hospital diagnoses primary hypertension and hyperlipidemia and performs relevant treatment such as blood pressure reduction. Dizziness, headache, dim eyesight and palpitation appear 2 days before the visit, and nausea and vomiting do not occur; no intolerance of cold and fever; has no symptoms of diarrhea, chest pain, etc., and the disease condition of the apocynum venetum is not relieved after the apocynum venetum is taken.
The von physician can support the treatment for the symptom after receiving the treatment, and the related examination is perfected; the patients are waited for the state of illness, the traditional Chinese medicine composition is taken according to the course of treatment, and the treatment scheme is adjusted at any time according to the change of the state of illness. After taking for 1 week, the disease condition is obviously improved, and after 2 weeks, dizziness and distending pain disappear completely. After the medicine is continuously taken for 1 week, the sleep quality is enhanced, the complexion is ruddy, the blood pressure is normal after the hospital is rechecked, and all indexes are basically normal.
Case 3
The patients are named after the prescription, male sex and 56 years old. Time of first visit: 11/month 2/2014.
The patients have myocardial infarction in the past history, and have taken medicines such as boli vitamin in hospitals. Chest distress, short breath and dizziness appear 1 week before the visit, palpitation accompany, fatigue can be aggravated, the rest can be relieved, the high blood pressure can be found by the blood test of the outpatient service of the hospital which is asked for many times, the highest blood pressure can reach 210/110mmH grams, and the examination of the electrocardiogram can prompt 'myocardial ischemia'. The symptoms of self-diagnosis become worse before treatment, dull pain in chest and mouth, and sometimes stopped, with symptoms of palpitation, shortness of breath, dizziness, especially after movement, but without fear of cold, fever, headache, vomiting, dyspnea, abdominal pain, abdominal distention, cough, expectoration, deafness, tinnitus, hemiplegia, aphasia, etc.
The medicines such as the vitamin A and the like are started to stop being taken for 3 days according to the treatment course; on the 7 th day, the heart is obviously smooth, the blood pressure is normal, and no pain is caused; after taking the medicine for 15 days, no disease symptoms exist, the sleep is good, and the mental state reaches the state before the disease occurs; the medicine can be used for 30 days to achieve radical cure. There were no recurrence to date.
Case 4
Patient Wangzhi, sex male, age 61 years. Time of first visit: 11/16/2014. Before treatment, the patients are often infused with cold due to the fatigue, pale face and poor mental status.
After the traditional Chinese medicine composition is taken for 3 to 5 days according to the treatment course, the face is gradually ruddy, the physique is enhanced, the common cold is avoided, and the mental state is changed.
Case 5
Patient Yan A, sex male, age 62 years. Time of first visit: 11/10/2014.
Before the visit, the company is examined as a typical patient with hypertension, hyperlipidemia and hyperglycemia, carries antihypertensive drugs with the patient every day, has pale face, obvious dark eye circles, poor sleep quality, occasional palpitations, short breath and chest distress, and slightly relieves the symptoms after about 1 hour of rest.
After the traditional Chinese medicine composition is taken for half a month according to the treatment course, the face is gradually ruddy, the mental state is well changed, and in 28095The Chinese patent medicine is easy to reveal in the ceremony, and advanced instrument detection is adopted, so that the traditional Chinese medicine composition is the only one tested person in the field, and all indexes are almost qualified.
Case 6
The patient is young, male in sex. Time of first visit: 11/12/2014.
The main symptoms before treatment are hemiplegia, inconvenient movement of the left hand and the left leg and unclear speaking. After the traditional Chinese medicine composition is taken for 2 weeks according to the treatment course, the hemiplegia symptom is relieved, and after the traditional Chinese medicine composition is taken for half a month, the hands are as the same as normal people, the left leg is slightly crippled, the mental state is better, and the sleep quality is better.
Case 7
Patients were tall for one lady, sexed women. Time of first visit: 12 and 10 months in 2014.
The main symptoms before treatment are rheumatic arthritis, thick finger joints and color spots on hands. The traditional Chinese medicine composition is taken for about 10 days according to the treatment course, the thick joints are recovered to be the same as those of normal people, the color spots on the hand are lightened, the sleep quality is improved, and the mental state is better than that before.
Case 8
The patients were showy, sexually male, and aged 50 years. Time of first visit: 1 month and 10 days 2014.
Hypertension before treatment, blood clots in the brain, bad mental status and poor sleep quality. The examination in hospital shows that the cerebral blood vessels are slightly blocked. After listening to the advice of the doctor and improving the diet, the Chinese medicinal composition of the invention is taken for 2 weeks according to the treatment course, the symptoms disappear, the blood pressure is stable, and the sleep quality is obviously improved
Case 9
The patient mourning, sex male, age 48 years old. Time of first visit: 15/4/2015.
In 2015, 1 month, car accidents, one leg fracture, filter screens, venous thrombosis of lower limbs, feeling but edema of legs, immobility and other normality. The diagnosis is vein blockage and thrombus at two legs. After the traditional Chinese medicine composition is taken for 1 week according to the treatment course, the vascular blockage is relieved, the thrombus is reduced, and after the traditional Chinese medicine composition is taken for 2 weeks, the veins of two legs are completely unblocked, and the thrombus disappears.
Case 10
The patient is a male with sex in a certain week and is 64 years old. Time of first visit: 10 and 12 days 2014.
The patient starts to feel pain in the area before the heart one week before the visit and radiates to the left shoulder, the pain can be relieved by rest, the similar condition attacks occur when the patient walks quickly in two days, each time lasts for 3-5 minutes, the nitroglycerin is quickly relieved, and the patient can take food, has normal stool, can sleep and has no obvious change in weight after the attack of the disease for the diagnosis and treatment. The past 5 years of hypertension history, the hospital diagnosis is coronary heart disease: unstable angina pectoris, hypertension. After the traditional Chinese medicine composition is taken for 2 days according to the treatment course, the pain symptom is relieved, and after 1 week, the blood pressure is within the range of normal people and the feeling of the heart area is good. After 2 weeks, the patient goes to a hospital to review, the coronary heart disease symptoms disappear, and the blood pressure is within the normal value range.
Case 11
Patient Zhangyi, gender, age 76 years. In the early period of patients, the heart radiography examination is carried out in the cardiology department of people's hospital in Shandong Jining City due to the discomfort of precordial region and the chest distress accompanied with pain, and the Wu main and ren in the cardiology department diagnoses that the coronary artery is blocked by 95 percent and the heart bypass operation must be carried out. After the traditional Chinese medicine composition is taken for 1 week according to the treatment course, discomfort symptoms are relieved, and pain disappears. After a course of treatment, the heart of the hospital is examined again by radiography, the coronary artery is basically unblocked, and all uncomfortable symptoms disappear.
The above cases prove that the invention has the following effects: reducing blood fat, changing blood viscosity, softening blood vessel, dissolving thrombus and dredging collaterals; reducing cholesterol and triglyceride, resisting thrombosis, and reducing apoplexy and myocardial infarction; it has effects in promoting blood circulation, relieving hyperlipidemia, reducing cholesterol and neutral fat in blood, reducing fat retention time on blood vessel wall, promoting dissipation of atherosclerotic plaque, and preventing vascular intimal injury caused by cholesterol.
Has unique curative effect on hyperlipidemia, atherosclerosis, cerebral arteriosclerosis, coronary heart disease, thromboangiitis obliterans, diabetic arteriosclerosis, multiple Takayasu arteritis, deep and superficial venous thrombosis, varicosis, nodular phlebitis, etc.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (6)
1. A traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is characterized by being prepared from the following raw materials in parts by weight: 20-30 parts of salvia miltiorrhiza, 15-25 parts of pseudo-ginseng, 15-25 parts of peach kernel, 10-20 parts of angelica, 10-20 parts of safflower, 10-20 parts of astragalus membranaceus, 10-20 parts of red paeony root, 5-15 parts of ligusticum wallichii, 5-15 parts of codonopsis pilosula, 5-15 parts of rhizoma polygonati and 1-10 parts of musk.
2. The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases according to claim 1, which is prepared from the following raw materials in parts by weight: 22-28 parts of salvia miltiorrhiza, 18-22 parts of pseudo-ginseng, 18-22 parts of peach kernel, 15-20 parts of angelica, 12-18 parts of safflower, 12-18 parts of astragalus membranaceus, 10-15 parts of red paeony root, 8-12 parts of ligusticum wallichii, 8-12 parts of codonopsis pilosula, 6-10 parts of rhizoma polygonati and 2-5 parts of musk.
3. The traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases according to claim 2, which is prepared from the following raw materials in parts by weight: 25 parts of salvia miltiorrhiza, 20 parts of pseudo-ginseng, 20 parts of peach kernel, 18 parts of angelica, 15 parts of safflower, 15 parts of astragalus, 12 parts of red paeony root, 10 parts of ligusticum wallichii, 10 parts of codonopsis pilosula, 8 parts of rhizoma polygonati and 3 parts of musk.
4. A preparation method of a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases is characterized by comprising the following steps:
(1) weighing the raw materials according to the parts by weight of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases of any one of claims 1 to 3;
(2) respectively crushing all the raw materials, sieving, and uniformly mixing to obtain mixed powder;
(3) drying the mixed powder obtained in the step (2) to obtain a semi-finished product;
(4) and (4) automatically and quantitatively packaging the semi-finished products obtained in the step (3) and warehousing.
5. The preparation method of the traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases according to claim 4, wherein in the step (2), the mesh number of the sieved screen is 180-200 meshes.
6. The preparation method of the Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases according to claim 4, wherein in the step (3), the drying temperature is 94-98 ℃, and the drying is carried out until the humidity of the mixed powder is 0.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911397275.2A CN113117017A (en) | 2019-12-30 | 2019-12-30 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911397275.2A CN113117017A (en) | 2019-12-30 | 2019-12-30 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113117017A true CN113117017A (en) | 2021-07-16 |
Family
ID=76767874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911397275.2A Pending CN113117017A (en) | 2019-12-30 | 2019-12-30 | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113117017A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113786459A (en) * | 2021-09-29 | 2021-12-14 | 北京孔氏中医院 | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491406A (en) * | 2014-12-10 | 2015-04-08 | 徐晓光 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation |
| CN104547519A (en) * | 2014-12-26 | 2015-04-29 | 青岛市市立医院 | A kind of traditional Chinese medicine preparation for treating coronary heart disease and preparation method thereof |
| CN105726932A (en) * | 2014-12-11 | 2016-07-06 | 青岛市黄岛区中医医院 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method thereof |
| CN106074784A (en) * | 2016-07-30 | 2016-11-09 | 邓殿刚 | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia |
-
2019
- 2019-12-30 CN CN201911397275.2A patent/CN113117017A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491406A (en) * | 2014-12-10 | 2015-04-08 | 徐晓光 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method of traditional Chinese medicine preparation |
| CN105726932A (en) * | 2014-12-11 | 2016-07-06 | 青岛市黄岛区中医医院 | Traditional Chinese medicine preparation for treating coronary heart disease and preparation method thereof |
| CN104547519A (en) * | 2014-12-26 | 2015-04-29 | 青岛市市立医院 | A kind of traditional Chinese medicine preparation for treating coronary heart disease and preparation method thereof |
| CN106074784A (en) * | 2016-07-30 | 2016-11-09 | 邓殿刚 | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113786459A (en) * | 2021-09-29 | 2021-12-14 | 北京孔氏中医院 | Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
| CN102772491B (en) | Traditional Chinese medicine composition for treating lower extremity atherosclerotic disease and application of composition | |
| CN102847074B (en) | Blood stasis removing pill for treating ankylosing spondylitis | |
| CN113117017A (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method | |
| CN104225532A (en) | Spleen-tonifying and kidney-warming pellets for treating ankylosing spondylitis | |
| CN104645249A (en) | Medicine for treating coronary heart disease and angina | |
| CN105343688A (en) | A kind of pharmaceutical composition for treating myocardial infarction and its application | |
| CN105535839A (en) | Traditional Chinese medicine tablets for treating colon cancer and preparation method thereof | |
| CN105287953A (en) | Preparation with uremia treating effect and preparation method | |
| CN117695343B (en) | A pharmaceutical composition for treating avascular necrosis of the femoral head and its preparation method | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN104306872A (en) | Traditional Chinese medicine for treating uterine fibroid | |
| CN104338052A (en) | Formula of traditional Chinese medicine for treating cerebral thrombosis | |
| CN103330911B (en) | Chinese medicine powder for treating coronary heart disease and preparation method thereof | |
| CN109464565A (en) | A kind of Chinese medicine composition and its preparation for treating chest impediment and cardialgia | |
| CN104258090A (en) | Astringent preparation for woman menostaxis and preparation method thereof | |
| CN105079392A (en) | Preparation for treating ischialgia and preparation method thereof | |
| CN105055596B (en) | A kind of treat chronic osteomyelitis and battalion's antiphlogistic bolus and preparation method thereof | |
| CN114748600A (en) | Traditional Chinese medicine composition for treating coronary heart disease in maintenance stage and preparation method thereof | |
| CN104667203A (en) | Medicine for treating coronary heart disease | |
| CN104771529A (en) | Drug for treating traumatic arthritis caused by deficiencies in liver and kidney and preparation method thereof | |
| CN105288184A (en) | Traditional Chinese medicine composition for treating depression and preparation method thereof | |
| CN113750064A (en) | A Chinese medicinal pill for treating cardiovascular diseases | |
| CN105288422A (en) | Traditional Chinese medicine preparation used for treating eilema syndromes and preparation method | |
| CN105125860A (en) | Preparation for effectively treating osteoporosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210716 |